Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.
Controlled study in people · 1992
- What was studied
- 16 patients; double-blind matched-pairs parallel groups
- Main finding
- In 16 chronic-insomnia patients, DSIP produced weak objective sleep differences and no consistent subjective sleep benefit; the authors found little likely therapeutic value.
Reported findings and study design
In 16 chronic-insomnia patients, DSIP produced weak objective sleep differences and no consistent subjective sleep benefit; the authors found little likely therapeutic value.
Double-blind matched-pairs parallel comparison: 8 DSIP, 8 glucose placebo; five laboratory nights.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Objective sleep | Higher efficiency and shorter latency, described as weak effects | Authors note possible contribution from incidental placebo-group changes |
| Subjective sleep quality | No change | No numerical sleep-minute difference in the abstract |
| Participants | 8 DSIP; 8 placebo | |
| Studied schedule | 25 nmol/kg IV before nights 3, 4 and 5 |
Design figures are available; objective effect sizes in minutes and confidence intervals are not. The original authors did not infer a major therapeutic benefit.
Source for these results ↗ · Reviewed 2026-11-01
Study limitations and source details
Study limitations
- Small, brief study; selected statistically significant endpoints do not establish a meaningful overall benefit.
Source details
Indexed metadata and abstract checked via PubMed / Europe PMC; full methods and risk-of-bias assessment pending.
Sources checked
Citation
Bes F, Hofman W, Schuur J, Van Boxtel C. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. Neuropsychobiology 26(4):193-197
Study source ↗ · DOI 10.1159/000118919 · Bibliography entry · Link to this summary